论文部分内容阅读
目的:比较经尿道前列腺等离子双极汽化电切术(PKRP)与前列腺电汽化术治疗老年前列腺增生症(BPH)的临床疗效。方法:选取138例老年良性前列腺增生症患者为研究对象,按照入院顺序随机均分为两组,观察组69例患者行经尿道前列腺等离子双极汽化电切术,对照组69例患者行前列腺电汽化术,比较分析两组患者手术时间、术中出血量、术后膀胱冲洗时间、住院时间、手术前后前列腺症状评分(I-PSS)、最大尿流率(Qmax)、手术并发症等。结果:观察组患者手术时间、术中出血量、术后膀胱冲洗时间、住院时间等指标均明显优于对照组(P<0.05)。治疗前观察组患者前列腺症状评分和最大尿流率与对照组比较差异无统计学意义(P>0.05);治疗后两组患者前列腺症状评分、最大尿流率均明显优于治疗前(P<0.05);治疗后对照组患者前列腺症状评分、最大尿流率优于治疗前,比较差异有统计学意义(P<0.05);治疗后观察组前列腺症状评分和最大尿流率改善情况优于对照组,但比较差异无统计学意义(P>0.05)。观察组患者术后性功能障碍发生率为4.35%,水中毒发生率为1.45%,前列腺包膜穿孔发生率为5.80%,均低于对照组(P<0.05)。结论:经尿道前列腺等离子双极汽化电切术可以达到与前列腺电汽化术治疗BPH相近的疗效,但其出血量少、手术时间短、术后恢复快、手术并发症少,是老年良性前列腺增生症症患者理想的治疗手段。
Objective: To compare the clinical efficacy of transurethral prostatic plasma bipolar vaporization (PKRP) and prostate electrosurgery for the treatment of benign prostatic hyperplasia (BPH). Methods: A total of 138 elderly patients with benign prostatic hyperplasia were enrolled in this study. Randomly divided into two groups according to the sequence of hospitalization. Sixty-nine patients in the observation group underwent transurethral vaporization of the prostate by bipolar plasmapheresis. Sixty-nine patients in the control group underwent electrovaporization of the prostate The operative time, intraoperative blood loss, postoperative bladder irrigation time, hospital stay, preoperative and postoperative prostate symptom score (I-PSS), maximal flow rate (Qmax) and surgical complications were compared between the two groups. Results: The operation time, intraoperative blood loss, postoperative bladder irrigation time and hospital stay in the observation group were significantly better than those in the control group (P <0.05). Prostate symptom score and maximal uroflow rate in the observation group before treatment were not significantly different from those in the control group (P> 0.05). Prostate symptom score and maximal uroflow rate in both groups were significantly better than those before treatment (P < 0.05). After treatment, the prostate symptom score and the maximum uroflow rate in the control group were better than those before treatment (P <0.05), and the improvement of the prostate symptom score and the maximal uroflow rate in the observation group was better than that of the control group Group, but the difference was not statistically significant (P> 0.05). The incidence of postoperative sexual dysfunction in observation group was 4.35%, the incidence of water poisoning was 1.45%, and the incidence of prostatic capsular perforation was 5.80%, both of which were lower than that of the control group (P <0.05). Conclusions: Transurethral plasmapapillary electrosurgical resection can achieve the same efficacy as prostate electrovaporization in the treatment of BPH. However, it has less bleeding, shorter operative time, faster postoperative recovery and fewer complications. It is an important characteristic of benign prostatic hyperplasia Ideal patient with symptomatic treatment.